Co-Diagnostics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Co-Diagnostics, Inc. (CODX) reported Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent of 21.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate · last filed 2026-08-13
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for the quarter ending 2026-06-30 was 21.00%.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for the quarter ending 2026-03-31 was 21.00%, a 0.00% change year-over-year.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for the quarter ending 2025-03-31 was 21.00%, a 0.00% change year-over-year.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for the quarter ending 2024-03-31 was 21.00%, a 0.00% change year-over-year.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for fiscal 2025 was 21.00%, a 0.00% change from fiscal 2024.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for fiscal 2024 was 21.00%, a 0.00% change from fiscal 2023.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for fiscal 2023 was 21.00%, a 0.00% change from fiscal 2022.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, at federal statutory income tax rate, percent for fiscal 2022 was 21.00%, a 0.00% change from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 3 month | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 6 month | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 9 month | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 21.00% 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 21.00% 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 21.00% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 21.00% 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 21.00% 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 21.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 21.00% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 21.00% 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 21.00% 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 21.00% 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 21.00% 10-K · filed 2025-03-27 | |||
| 2023-09-30 | 21.00% 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 21.00% 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | 21.00% 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 21.00% 10-K · filed 2024-03-14 | |||
| 2022-09-30 | 21.00% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 21.00% 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 21.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 21.00% 10-K · filed 2023-03-16 | |||
| 2020-12-31 | 21.00% 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |